theravia is a leading international pharmaceutical company focused on rare and neglected diseases. 

Established through the merger of Addmedica and CTRS, we are committed to tackling the unmet medical needs of patients facing these difficult conditions.

For more information, please visit our website: https://theravia.com

theravia

The office at 16 rue Montrosier focuses on regulatory affairs and project management in the pharmaceutical sector.

16 rue Montrosier

Amaury Hemar

This department focuses on managing and nurturing relationships with key accounts to drive business growth and customer satisfaction.

Key Account Management

This department focuses on the development and commercialization of treatments for rare diseases, encompassing research, medical advice, and marketing strategies.

Rare Disease Program

This department manages compliance with regulations and oversees projects related to regulatory submissions and pharmacovigilance.

Regulatory Affairs

This department addresses legal matters, providing guidance and support on compliance, contracts, and risk management.

Legal Department

This department oversees the coordination and execution of operational activities and services within the organization.

Operations Management

This department oversees drug safety monitoring and ensures compliance with quality standards in pharmaceutical practices.

theravia

Org chart

Teams

Key Account Management

Rare Disease Program

Regulatory Affairs

Legal Department

Operations Management

Pharmacovigilance and Quality

Offices

theravia

Org chart

Teams

Key Account Management

Rare Disease Program

Regulatory Affairs

Legal Department

Operations Management

Pharmacovigilance and Quality

Offices

Related companies